Vitkovice Hospital
Ostrava-Vitkovice, 70384, Czechia
NCT Number: NCT02077088
Addition of prebiotic galactooligosaccharides to hypoallergenic starter formula would lead to decreased allergic (atopic) symptoms in nonbreastfed infants with a positive history of allergy in family
Looking for future studies?
Notify Me6 week–8 week
All sexes
Interventional
Not applicable
Ostrava-Vitkovice, 70384, Czechia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
addition of food grade GRAS (Generally Regarded As Safe) galactooligosaccharides
Other names: GOS, prebiotics
Time frame: at 6 months of age
objective evaluation of atopic symptoms
Time frame: at 6 months of age
Time frame: at 6 months
Humana Co.Ltd.
Industry
Double Blind, Randomised Study on the Effect of Prebiotics on Incidence of Atopic Manifestations in Infants
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05990725
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Augsburg, Germany
View Trial DetailsNCT05916365
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Darmstadt, Hesse, Germany
View Trial DetailsNCT06585202
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Birmingham, Alabama, United States
View Trial DetailsNCT04392154
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Anniston, Alabama, United States
View Trial Details